Procter & Gamble Management
Management Kriterienprüfungen 4/4
Procter & Gamble CEO ist Shailesh Jejurikar , ernannt in Jan 2026, hat eine Amtszeit von weniger als einem Jahr. Die jährliche Gesamtvergütung beträgt $9.59M , bestehend aus 12.1% Gehalt und 87.9% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.004% der Aktien des Unternehmens, im Wert von $12.53M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 3.6 Jahre bzw. 4.7 Jahre.
Wichtige Informationen
Shailesh Jejurikar
Geschäftsführender
US$9.6m
Gesamtvergütung
| Prozentsatz des Geschäftsführergehalts | 12.12% |
| Amtszeit als Geschäftsführer | less than a year |
| Eigentum des Geschäftsführers | 0.004% |
| Durchschnittliche Amtszeit des Managements | 3.6yrs |
| Durchschnittliche Amtszeit der Vorstandsmitglieder | 4.7yrs |
Jüngste Management Updates
Recent updates
Narrativ-Update • May 04
PG: Brand Partnerships And Product Pipeline Will Support Future Shareholder Returns
Analysts have trimmed their Procter & Gamble price target slightly to about $164.09, reflecting modestly lower assumptions for revenue and profit margins while applying a slightly higher future P/E outlook. What's in the News P&G maintained fiscal 2026 guidance, with all-in sales growth expected in a 1% to 5% range and diluted EPS growth targeted in a 1% to 6% range versus fiscal 2025 diluted EPS of US$6.51 (Corporate guidance).Seeking Alpha • Apr 25
Procter & Gamble: Fundamentals Are Solid, But The Price Is Too High - Downgrading From Buy To Hold
Summary Procter & Gamble is downgraded from buy to hold due to macroeconomic headwinds and valuation concerns. PG continues to deliver robust, broad-based organic sales growth of 3%, with strength in both volume and pricing. The company’s growth is well-diversified across regions and product categories, underscoring resilience despite poor consumer confidence. Current valuation does not adequately reflect heightened macro uncertainty, making a hold rating more justifiable at this time. Read the full article on Seeking Alpha
Neues Narrativ • Apr 24
Procter & Gamble (PG): The Beauty-Driven Beat and the Resilience of Staples
Procter & Gamble (PG) , the global vanguard of consumer staples, enters the afternoon of Friday, April 24, 2026 , as a beacon of stability following its Q3 Fiscal 2026 earnings report released this morning. The Cincinnati-based giant delivered a solid "beat-and-raise" performance, reporting Core EPS of $1.59 , surpassing the Wall Street consensus of $1.56.Narrativ-Update • Apr 20
PG: Buybacks And Brand Partnerships Will Support Future Shareholder Returns
Analysts have slightly reduced their price target on Procter & Gamble to $164.18 from $166.95, reflecting modestly lower assumptions for revenue growth, profit margins, fair value, and future P/E multiples. What's in the News P&G revised its fiscal 2026 diluted EPS growth outlook to a range of 1% to 6%, from a prior range of 3% to 9%, citing higher non core restructuring charges, while keeping all in sales growth guidance at 1% to 5% versus the prior year (Corporate guidance).Narrativ-Update • Apr 05
PG: Share Repurchases And Premium Portfolio Refresh Will Support Future Returns
Analysts have slightly reduced their average price target for Procter & Gamble to about $167 from $168, reflecting updated views on margins and forward P/E assumptions while keeping core growth expectations largely intact. What's in the News OLAY shared new skin aging research at the 2026 American Academy of Dermatology meeting, focusing on cell adhesion as a key factor in visible aging and applying these findings to peptide based products across the Regenerist line and the new Regenerist Treatments collection (Product announcement).Narrativ-Update • Mar 22
PG: Product Refresh And Buybacks Will Support Future Earnings Resilience
Analysts kept their Procter & Gamble price target steady at $168. This reflects largely unchanged views on fair value, discount rate, revenue growth, profit margin, and future P/E assumptions.Narrativ-Update • Mar 08
PG: Brand Refresh And Buybacks Will Support Stable Earnings Outlook
Analysts have maintained their Procter & Gamble price target at $168, reflecting unchanged assumptions around revenue growth, profit margins, and future P/E. This suggests that recent research has not materially shifted their valuation view.Narrativ-Update • Feb 21
PG: Brand Activity And Buybacks Will Support Stable Margins And Outlook
Analysts have nudged their price target for Procter & Gamble higher to $168.00 from $167.45, reflecting updated assumptions for revenue growth, slightly higher profit margins and a marginally lower future P/E multiple. What's in the News Tide launched Tide evo, a 100% concentrated, waterless laundry tile with six cleaning layers and no plastic bottles, positioned to address demand for products that align with hygiene and sustainability preferences in the U.S. (Product related announcement) Head & Shoulders introduced BARE Itchy Scalp Relief Serum, aimed at providing clinically tested dandruff protection and itch relief between washes, with a nationwide U.S. launch planned for January 2026.Narrativ-Update • Feb 07
PG: Premium Brand Extensions And Stable Margins Will Support A Balanced Outlook
Analysts have nudged their price target on Procter & Gamble slightly higher to US$167.45 from about US$165.32, reflecting updated assumptions for fair value, discount rate, revenue growth, profit margins and future P/E. What's in the News Old Spice launched the Spice Alchemist collection, a premium cologne-infused deodorant, body wash and body mist line positioned against high end fragrances.
Narrativ-Update • Jan 25
Q2 2026 Update
Update narrative with most recent financial statements.Narrativ-Update • Jan 23
PG: Share Repurchases And Margin Pressures Will Shape A Balanced Outlook
Analysts have trimmed their price target on Procter & Gamble to US$165 from US$168, citing updated views on revenue growth, profit margins, and the future P/E multiple. What's in the News P&G updated its fiscal 2026 guidance, keeping all in sales growth for the year in a range of 1% to 5% versus the prior year, while lowering the diluted EPS growth outlook to 1% to 6% from the previous 3% to 9% range, citing higher non core restructuring charges versus fiscal 2025 diluted EPS of US$6.51 (Corporate guidance).Narrativ-Update • Jan 07
PG: Share Repurchase Will Support Future Upside With Stable Long Term Outlook
Narrative Update on Procter & Gamble The analyst price target for Procter & Gamble has shifted slightly, with updated assumptions around fair value at about $168.13, discount rate at 6.96%, revenue growth at roughly 3.12%, profit margin near 19.58%, and future P/E around 26.08x, as analysts fine tune their models on the company. What's in the News Pantene is partnering again with social media creator Alix Earle to promote the Abundant & Strong 3-Step System, including limited-edition Alix x Pantene Kits that bundle the three products with a free cosmetics bag and hairbrush for a limited time (product-related announcement).Narrativ-Update • Dec 16
PG: Share Repurchase Will Support Future Upside Amid Stable Long Term Outlook
Analysts have nudged their price target for Procter & Gamble slightly lower to approximately $168.50 from about $169.05, reflecting modestly softer long term revenue growth expectations that are only partially offset by a marginally improved profit margin outlook and a slightly lower assumed future valuation multiple. What's in the News Pantene launched the Abundant & Strong Collection, a three step system clinically shown to reduce hair loss by up to 85% by targeting scalp oxidative stress with a Pro Vitamin Complex plus Niacinamide technology.Narrativ-Update • Dec 02
PG: Share Repurchase And New Collections Will Drive Continued Momentum
Procter & Gamble's analyst price target remains unchanged at $169.05 as analysts maintain stable estimates based on consistent fair value metrics and minimal adjustments to key financial assumptions. What's in the News Pantene launches the Abundant & Strong Collection, a new three-step system designed to reduce hair loss by up to 85% and promote stronger, denser hair using antioxidant technology.Narrativ-Update • Nov 18
PG: Share Buybacks And New Guidance Will Support Steady Uptrend
Analysts have maintained Procter & Gamble's price target at $169.05 per share. There have been only minor adjustments to underlying valuation factors, supporting a steady outlook for the company.Narrativ-Update • Nov 03
PG: Share Buyback And Product Rollout Will Drive Long-Term Upside
Analysts have slightly raised their price target for Procter & Gamble to $169.05 from $168.64. They cite incremental improvements in revenue growth forecasts even as profit margin projections moderate.Narrativ-Update • Oct 20
Rising Consumer Confidence And Product Investment Will Expand US Markets
Analysts have slightly lowered their price target for Procter & Gamble from $170.95 to $168.64 per share. They cite modest reductions in projected revenue growth, which are partially offset by improved profit margins and valuation multiples.Analyseartikel • Aug 06
The Procter & Gamble Company (NYSE:PG) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?
NYSE:PG 1 Year Share Price vs Fair Value Explore Procter & Gamble's Fair Values from the Community and select yours The...Neues Narrativ • Jul 21
Procter & Gamble: A Dividend Giant Facing Slowing Growth
United States: 48.21%1-Year Revenue Growth = 4.65%Analyseartikel • Jun 27
The Procter & Gamble Company (NYSE:PG) Shares Could Be 21% Below Their Intrinsic Value Estimate
Key Insights The projected fair value for Procter & Gamble is US$200 based on 2 Stage Free Cash Flow to Equity Procter...Seeking Alpha • Apr 22
Procter & Gamble: Hold This Stodgy Stalwart
Summary Procter & Gamble is a global consumer product leader, with a strong market presence and consistent, albeit slow, growth in revenue and earnings. Despite being overvalued, PG's profitability remains robust, with reliable cash flow and a solid gross profit margin above industry medians. PG's valuation poses a risk, with a high PEG ratio indicating slow growth, yet it maintains a decent dividend yield and outpaces peers in performance. PG is a safe investment but lacks excitement; it's a hold due to its steady but lethargic growth and overvaluation concerns. Read the full article on Seeking AlphaAnalyse der Geschäftsführervergütung
| Datum | Gesamtvergütung | Gehalt | Unternehmensgewinne |
|---|---|---|---|
| Mar 31 2026 | n/a | n/a | US$16b |
| Dec 31 2025 | n/a | n/a | US$16b |
| Sep 30 2025 | n/a | n/a | US$16b |
| Jun 30 2025 | US$10m | US$1m | US$16b |
| Mar 31 2025 | n/a | n/a | US$15b |
| Dec 31 2024 | n/a | n/a | US$15b |
| Sep 30 2024 | n/a | n/a | US$14b |
| Jun 30 2024 | US$10m | US$1m | US$15b |
| Mar 31 2024 | n/a | n/a | US$15b |
| Dec 31 2023 | n/a | n/a | US$14b |
| Sep 30 2023 | n/a | n/a | US$15b |
| Jun 30 2023 | US$8m | US$1m | US$14b |
| Mar 31 2023 | n/a | n/a | US$14b |
| Dec 31 2022 | n/a | n/a | US$14b |
| Sep 30 2022 | n/a | n/a | US$14b |
| Jun 30 2022 | US$7m | US$953k | US$14b |
| Mar 31 2022 | n/a | n/a | US$14b |
| Dec 31 2021 | n/a | n/a | US$14b |
| Sep 30 2021 | n/a | n/a | US$14b |
| Jun 30 2021 | US$6m | US$798k | US$14b |
Vergütung im Vergleich zum Markt: ShaileshDie Gesamtvergütung ($USD9.59M) liegt unter dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt US ($USD14.78M).
Entschädigung vs. Einkommen: ShaileshDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.
Geschäftsführer
Shailesh Jejurikar (57 yo)
less than a year
Amtszeit
US$9,591,687
Vergütung
Mr. Shailesh G. Jejurikar was Independent Director at Otis Worldwide Corporation (also known as Otis Elevator Company, Inc) since April 03, 2020 until September 9, 2025. He serves as CEO & President at The...
Führungsteam
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| Executive Chairman | 4.8yrs | US$21.91m | 0.016% $ 54.2m | |
| CEO, President & Director | less than a year | US$9.59m | 0.0038% $ 12.5m | |
| Chief Financial Officer | 5.2yrs | US$8.52m | 0.0026% $ 8.6m | |
| Chief Executive Officer of Health Care | 8.3yrs | US$6.04m | 0.0033% $ 11.0m | |
| Chief Executive Officer of Fabric and Home Care and P&G Ventures | 1.3yrs | US$7.18m | 0.0022% $ 7.2m | |
| Senior VP & Chief Accounting Officer | 3.8yrs | keine Daten | 0.00018% $ 598.2k | |
| Chief Information Officer | 1.8yrs | keine Daten | keine Daten | |
| Senior Vice President of Investor Relations | no data | keine Daten | keine Daten | |
| Chief Legal Officer & Secretary | 4.3yrs | keine Daten | 0.0016% $ 5.3m | |
| Chief Communications Officer | 6.2yrs | keine Daten | keine Daten | |
| President of North America & Chief Sales Officer | no data | keine Daten | keine Daten | |
| Chief Human Resources Officer | 3.3yrs | US$7.48m | 0.00077% $ 2.6m |
3.6yrs
Durchschnittliche Betriebszugehörigkeit
53.5yo
Durchschnittliches Alter
Erfahrenes Management: PGDas Führungsteam des Unternehmens gilt als erfahren (3.6 Jahre durchschnittliche Betriebszugehörigkeit).
Vorstandsmitglieder
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| Executive Chairman | 4.8yrs | US$21.91m | 0.016% $ 54.2m | |
| CEO, President & Director | less than a year | US$9.59m | 0.0038% $ 12.5m | |
| Independent Director | 6.6yrs | US$370.00k | keine Daten | |
| Independent Director | 5.8yrs | US$340.00k | keine Daten | |
| Lead Independent Director | 8.2yrs | US$410.00k | 0.00054% $ 1.8m | |
| Independent Director | 3.6yrs | US$340.00k | keine Daten | |
| Independent Director | 3.1yrs | US$340.00k | keine Daten | |
| Independent Director | 2.6yrs | US$340.00k | keine Daten | |
| Independent Director | 5.3yrs | US$340.00k | keine Daten | |
| Independent Director | 8.9yrs | US$360.00k | keine Daten | |
| Independent Director | 4.6yrs | US$340.00k | keine Daten | |
| Independent Director | 3.1yrs | US$340.00k | keine Daten |
4.7yrs
Durchschnittliche Betriebszugehörigkeit
60yo
Durchschnittliches Alter
Erfahrener Vorstand: PGDie Vorstandsmitglieder gelten als erfahren (4.7 Jahre durchschnittliche Amtszeit).
Unternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/05/15 17:43 |
| Aktienkurs zum Tagesende | 2026/05/15 00:00 |
| Gewinne | 2026/03/31 |
| Jährliche Einnahmen | 2025/06/30 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
The Procter & Gamble Company wird von 43 Analysten beobachtet. 21 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Christopher Graja | Argus Research Company |
| Lauren Lieberman | Barclays |
| Lauren Lieberman | Barclays |